Drug reference
hepatitis b virus vaccine
recombinant protein vaccine · vaccine
recombinant protein vaccinevaccine
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
The hepatitis B virus vaccine is a recombinant protein vaccine produced in yeast, containing the protective hepatitis B surface antigen. It induces immunity to prevent hepatitis B virus infection, which can cause life-threatening and chronic liver disease.
Indications
prevention of hepatitis B virus infection
Dosing
- Pediatric
- All infants receive the hepatitis B vaccine. When the mother has active infection, the neonate is treated with both the vaccine and hepatitis B immune globulin.
Related guidelines
Hepatitis B — chronic infection
EASL · Gastroenterology · 2025
Hepatitis B — chronic infection
INASL · Gastroenterology · 2023
Hepatitis B — chronic infection
WHO · Hepatology · 2025
Hepatitis C — chronic infection
EASL · Gastroenterology · 2020
Skin and soft tissue infections
IDSA · Infectious Diseases · 2010
Ask House about hepatitis b virus vaccine
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: Goodman & Gilman 14e·Updated: 2026-05-10